Company / Operating Cash Flow
ALX ONCOLOGY HOLDINGS INC Operating Cash Flow History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$89.2M
FY2022
5-year range
-$89.2M / -$13.2M
FY2020-FY2022
Trend
-526.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow changed -526% YoY in FY2022, a notable deviation from the 2-year average annual change of -267%.
Based on SEC 10-K filings.
-$89M in FY2022.
Declined from -$13M to -$89M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow decreased 526.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$89.2M | -526.2% |
| FY2021 | -$14.2M | -8.0% |
| FY2020 | -$13.2M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026